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Abstract: Porous bone tissue engineering scaffolds were fabricated using both nano 
hydroxyapatite (nano HA) powder (20 nm average particle size) and micro HA powder (10 µm 
average particle size), resulting in sintered scaffolds of 59 vol% porosity and 8.6±1.9 µm average 
grain size and 72 vol% porosity and 588±55 nm average grain size, respectively. Scanning 
electron microscopy was used to measure both the grain size and pore size. MC3T3-E1 
osteoblast (OB) attachment and proliferation on both nano HA and micro HA porous scaffolds 
were quantified. As expected, OB cell number was greater on nano HA scaffolds compared 
with similarly processed micro HA scaffolds 5 days after seeding, while OB attachment did 
not appear greater on the nano HA scaffolds (p<0.05). 
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Introduction
Bone is a composite material having a calcium phosphate (CaP) mineral component 
and a collagen-based organic matrix. CaP is a bioceramic resembling hydroxyapatite 
(HA, Ca10(PO4)6(OH)2), where the individual crystals have a plate-like morphology, 
15–200 nm in length and 10–80 nm in width with a thickness between 2 and 7 nm (Fratzl 
et al 2004). These apatite crystals are embedded within the collagen fiber component 
of the organic matrix, which forms lamellar sheets comprising the concentric rings 
of osteons in cortical bone (Young and Heath 2000) and the more woven structure 
of trabeculae in cancellous bone (Hassenkam et al 2004). The collagen matrix is 
composed primarily of Type I collagen fibers of approximately 100 nm in diameter 
(Fratzl et al 2004).
These nano-components play an active role in bone development and growth. 
Collagen fibers act as the scaffold on which newly formed nanocrystals of bone apatite 
form and grow, leading eventually to the formation of woven bone. This primitive early 
phase of bone is eventually replaced by the lamellae of adult bone (Young and Heath 
2000). Additionally, collagen fibers have been shown to incorporate into porous HA 
tissue engineering scaffolds where the interfacial zone between bone and scaffold has 
been found to be a nano HA-reinforced collagen matrix (Chen et al 2004).
One area of current research in biomimetic nano-scale ceramic bone substitute 
materials is therefore focused on the design of nanoscale ceramic–polymer composites 
to mimic some of the morphological features of natural bone. These systems can be 
grouped into three categories: nano-CaP–collagen (Du et al 1998; Du et al 1999; Sakane 
et al 2004), nano-CaP–noncollagen polymer (Wei et al 2003, 2004a, 2004b), and a 
combination of the two (Cui et al 2004; Liao et al 2004). Although there are several types 
of CaP bioceramics, HA is the most commonly used, having a chemistry that closely 
matches that of normal bone apatite (Jarcho 1981; Hench 1998; Li et al 2004). 
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Nanocrystalline HA has been shown to be biocompatible 
with a minimal inflammatory response (Huang et al 2004; 
Silva et al 2004), although there is a potential for cytotoxicity 
(Huang et al 2004). While some engineered nano-CaP–
polymer composites such as HA–collagen polylactic acid 
(PLA) scaffolds have been reported to show improvements 
in compressive strength using nano HA (Liao et al 2004), 
they did not replicate the hierarchical structure of bone which 
may be crucial in encouraging bone ingrowth into a tissue 
engineered scaffold (Du et al 1998; Liao et al 2004). Also, 
Yoneda et al (2004) confirm that the degradation of PLA 
adversely affects cell behavior, specifically that increased 
degradation leads to a decrease in cell spreading, adhesion, 
and cell survival. Therefore, current research focuses on 
developing a bioceramic with a morphological structure 
similar to that of normal bone to promote bone regeneration 
in vitro and in vivo (Longsworth and Eppell 2002).
Webster et al compared changes in osteoblast (OB) 
behavior on nano-grained versus micro-grained dense 
bioceramics, including Al2O3, TiO2, and HA, demonstrating 
increases in OB attachment (Webster, Ergun, et al 1999; 
Webster et al 1999a, 1999b) and proliferation, alkaline 
phosphatase (AP) activity, and calcium deposition, as well as 
decreased cell motility (Webster, Ergun, et al 1999; Webster 
et al 2000a). 
Osteoblast attachment on a bioinert ceramic like 
Al2O3 can be attributed to the presence of physical surface 
irregularities that lead to increased morphological fixation 
(Hench 1998). Such fixation in turn plays an important role 
in the use of TiO2 as a coating for orthopedic implants, 
improving the integrity of the implant–bone interface (Areva 
et al 2004).
 Fixation also plays a role in OB attachment to HA, 
but increased osteoblast adhesion may also occur because 
of improved protein interactions that have been linked to 
decreases in grain size (Webster et al 2000b).
Enhanced OB behavior for HA having a finer grain size 
is further illustrated in a study by Xie et al (2004), which 
recently reported that MC3T3-E1 OBs seeded onto dense 
HA discs showed differences in gene expression related to 
grain boundary surface area. Gene expression of OBs on 
HA discs fabricated with an average particle size of 35 µm 
suggest a decrease in cellular metabolism and an increase 
in differentiation while HA discs processed from smaller 
particle sizes (~11 µm) showed gene expression profiles 
consistent with increased cell growth. Each of the previous 
studies was conducted using dense ceramic scaffolds, 
designed specifically for cell culture purposes, while the 
current study assesses whether porous bone replacement 
scaffolds fabricated with nano HA powder rather than micro 
HA improves OB attachment and proliferation.
Materials and methods
HA powder, of 10 µm average particle size, was purchased 
from Hitemco Medical (Old Bethpage, NY, USA) and used 
in its as-received form. Nano-scale HA powder having an 
average particle size of 20 nm was purchased from Berkeley 
Advanced Biomaterials (San Leandro, CA, USA). The nano 
HA powder arrived in an ammonium hydroxide suspension 
which was subsequently centrifuged, resuspended in ethanol, 
centrifuged again to separate out the nano HA powder, and 
then vacuum dried for 12 hours before use (per manufacturer 
instructions).
Methods used in this study can be divided into four parts: 
scaffold fabrication, imaging of scaffold surfaces, osteoblast 
cell culture, and assessment of OB attachment and proliferation. 
Porous cylindrical samples of each HA powder particle 
size were foamed by suspending the HA powders in KNO3 
electrolyte to which H2O2 had been added, pouring the 
resulting foamed suspension into cylindrical molds and 
drying at 125°C. The dry, green HA samples were then 
sintered at 1100°C for 1 hour (nano HA) following the 
procedure established by Webster et al (Webster, Ergun, et 
al 1999; Webster et al 2000a, 2000b) or 1360°C for 4 hours 
(micro HA) using a protocol developed by McMullen (2004). 
Both the micro and nano HA-sintered scaffolds were next 
sectioned using a Buehler IsoMet 1000 diamond abrasive 
wafering saw (Buehler, Lake Bluff, IL, USA) into discs of 
approximately 1mm thickness and autoclaved.
Nano HA and micro HA scaffold surfaces were observed 
using scanning electron microscopy (SEM). Samples 
were coated with a thin layer of Au, approximately 21 nm 
thick, using an Emscope SC500 sputter coater (Emscope 
Laboratories Ltd, Ashford, UK), mounted onto Al stubs 
and imaged using a JEOL 6400 SEM (JEOL Corporation, 
Tokyo, Japan) operated at an accelerating voltage of 5keV . 
SEM photomicrographs were collected and exported using 
the AnalySIS software package. 
MC3T3-E1 OBs of passage 22–23, cultured in alpha 
minimum essential medium (α-MEM) supplemented with 
10% fetal bovine serum (FBS), were trypsinized, resuspended 
in α-MEM, and seeded evenly across the surface of porous 
HA scaffolds at a density of 11320 cells/cm
2 and incubated 
in air at 37°C, 5% CO2, and high humidity (Shu et al 2003). 
2 mL of α-MEM was added per specimen and was replenished 
every 2 days. Three specimens were statically cultured per 
time interval and 2 sets of cultures were examined, resulting International Journal of Nanomedicine 2006:1(2) 191
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in 6 samples per time interval. MC3T3-E1 OBs are a widely 
used OB cell line (Cerroni et al 2002; Werner et al 2002; 
Shu et al 2003; Iyer et al 2004; Xie et al 2004) that have 
been shown to behave in a similar manner to primary OBs 
(Griffin et al 2005).
OB attachment was assessed at intervals of 0.5, 1, 2, and 
4 hours. Scaffolds were removed, placed into separate wells, 
rinsed with phosphate-buffered saline (PBS), trypsin/α-MEM 
(50/50) added, and the scaffolds morselized to facilitate 
osteoblast detachment. Media was drawn from each well and 
the OBs counted using a hemacytometer. OB cell counts were 
also conducted at 1, 3, and 5 days following attachment to 
assess OB proliferation. 
Statistical differences between attachment and growth 
on micro HA and nano HA scaffolds were calculated using 
Student’s t tests. A p value of 0.05 or lower was considered 
to be significant.
Results
Porous HA scaffolds were successfully fabricated by 
foaming and sintering both micro HA and nano HA powder 
as described in the previous section. SEM showed that the 
micro HA scaffolds have a grain size of 8.6±1.9 µm which is 
approximately 15 times greater than the nano HA grain size 
of 588±55 nm (representative micrographs given in Figure 1). 
The average grain size was determined using a line-intercept 
method (n=50) based on ASTM standard E 112 (ASTM 
2004). The volume porosity of micro HA and nano HA 
scaffolds using Archimedes method were found to be 59 vol% 
and 72 vol %, respectively (McMullen 2004). Both micro and 
nano HA scaffold surfaces consisted of grains which are the 
sintered particles interspersed with frequent gaps along with 
larger macropores–micropores of 390±210 µm–38±22 µm for 
micro HA and 480±275 µm–30±21 µm for nano HA. These 
size ranges fall within standard macropore (200 µm–400 µm) 
and micropore (<60 µm) ranges reported by deGroot et al 
(1988). A representative SEM photomicrograph showing the 
nature and distribution of the porosity within the pore wall 
of a nano HA scaffold is given in Figure 2.
Contrary to published data by Webster et al using dense 
HA scaffolds, these results show that initial OB attachment 
does not increase as a function of decreased grain size on 
porous HA scaffolds (Webster, Ergun, et al 1999; Webster 
et al 2000a, 2000b, 2001). MC3T3-E1 OB attachment on   
porous scaffolds is plotted as a function of time for 0.5, 1, 2, 
and 4 hours (Figure 3). Based on hemacytometer analysis, OB 
attachment on the micro HA scaffolds appears greater than 
on the nano HA scaffolds and differences were statistically 
significant (with p<0.05).
When OB cell number is examined, the mean values for 
OB proliferation on nano HA scaffolds are higher compared 
with the mean values on micro HA scaffolds (Figure 4) at 
1, 3, and 5 days’ culture time. Differences in proliferation 
between micro HA and nano HA scaffolds at 1 and 3 days 
were not found to be statistically significant, with p>0.05 in 
both cases (p=0.64 and p=0.12, respectively). However, at 
5 days, differences in osteoblast number were found to be 
significant (p<0.05).
Discussion
Porous bioceramic scaffolds offer advantages over dense 
substrates for bone tissue engineering applications, because 
Figure 1  Comparison of SEM micrographs of the surface of scaffolds fabricated 
using micro HA (left) and nano HA (right).
Abbreviations Figures 1–4: HA, hydroxyapatite, OB, osteoblast.
Figure 2  SEM micrograph showing the surface of porous scaffold fabricated using nano 
HA, including macropores (large arrows noting approximate boundary of a macropore) 
and micropores (small arrows emphasizing the <60 μm interconnecting pores).International Journal of Nanomedicine 2006:1(2) 192
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they present a more complex interface for bone ingrowth 
that more closely mimics natural bone (Hench 1998; Hulbert 
et al 1970, 1972). Additionally, porous CaP ceramics are 
capable of promoting osteoprogenitor attachment and new 
bone formation (Ohgushi et al 1990). Osteoprogenitor 
cells cultured on porous HA have been shown to produce 
extracellular matrix in vivo, a precursor to bone formation 
(Ohgushi et al 1990). Therefore, it is important to observe 
the effect of HA grain size reduction on OB behavior and 
to examine these differences for porous scaffolds which are 
more suited for bone tissue engineering applications.
 Foaming and sintering nano HA with a particle size 
of 20 nm yielded porous scaffolds of submicron grain 
size (588 nm±55 nm). While this grain size is not truly 
nanoscale (<100 nm), it is small enough to assess the effect 
of grain size reduction (15x) on OB behavior in vitro. This 
reduction in grain size means that there is an increased grain 
boundary surface area, which has been tied to increased OB 
attachment (Perla et al 2004) and enhanced gene expression 
(Xie et al 2004) indicative of increased cell growth and 
differentiation. Reduction in grain size has also been linked 
to increased surface roughness, which in turn has been 
shown to increase OB adhesion, proliferation, AP activity, 
and calcium production (Webster 2001). In future studies, 
atomic force microscopy (AFM) will be used to measure the 
surface roughness of these scaffolds, to determine whether 
these results are repeatable for porous HA. 
Webster et al have repeatedly shown that a large decrease 
in HA grain size produces changes in osteoblast activity, 
including improvements in attachment and proliferation 
(Webster, Ergun, et al 1999; Webster et al 2000a, 2000b, 2001). 
Results of this study both contradict (OB attachment) and 
reinforce (OB proliferation) these findings. Our study shows 
that OB attachment did not improve on scaffolds fabricated 
from nano HA powder compared with those produced from 
micro HA powder. However, each of Webster’s studies used 
dense HA having a sintered grain size of 67 nm (Webster et al 
2000a, 2000b), which is ~11% of our sintered grain size and 
only 1/3 larger than their unsintered particle size. In contrast, 
our scaffolds have grains 30 times larger than our unsintered 
particles. This difference in grain growth in our scaffolds, 
from 20 nm–588±55 nm, is likely an artifact of the highly 
porous nature of our scaffolds in which the predominant 
sintering mechanism is coarsening (Barsoum 1997). Future 
studies will investigate the sintering behavior of these foamed 
nano HA scaffolds with the goal of reducing grain growth to 
yield true high volume porosity nanograined HA scaffolds.
At each time period, 0.5, 1, 2, and 4 hours, hemacytometer 
analyses suggest an increase in cell number (attachment) on 
micro HA scaffolds compared with nano HA scaffolds. This 
suggests that increased grain size is not positively related 
to OB attachment behavior in highly porous scaffolds. 
However, the cell attachment values for both scaffolds are 
much larger in this study than expected. This suggests that 
HA particles themselves may have been included in the 
cell counting analyses. This was a more significant issue 
when counting the OBs from the micro HA scaffolds where 
the morselized scaffold particles were of a similar size in 
comparison with the OBs. In contrast, the nano HA scaffolds 
morselized into significantly smaller fragments that were 
easily distinguishable from the much larger OBs. This is 
reflected in the apparent and uniform shifting upwards of the 
OB attachment data in Figure 3 for the micro HA. However, 
as this experimental cell counting technique was consistently 
applied, the differences noted at day 5 in Figure 4 are still 
significant. Future studies will be done by normalizing such 
attachment and proliferation data against a background count 
of morselized scaffold without cells.
While OB attachment did not increase with decreased 
grain size, the mean OB proliferation, measured at 1, 3, and 5 
0
100
200
300
400
500
600
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
Time (Hours)
%
 
P
l
a
t
e
d
Figure 3  MC3T3-E1 OB attachment on micro HA (dashed line) and nano HA (solid 
line) scaffolds as a function of time, at intervals of 0.5, 1, 2, and 4 hours. Values are 
mean±SE, p<0.05 at all time intervals for comparison of nano HA with micro HA.
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Figure 4  MC3T3-E1 OB proliferation on micro HA and nano HA, after periods of 
1, 3, and 5 days. Values are mean±SE, p>0.05 for comparison of nano HA with micro 
HA porous scaffold for 1 and 3 days. p<0.05 for 5 days (‡).International Journal of Nanomedicine 2006:1(2) 193
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days, on nano HA scaffolds was higher than the mean values 
for the micro HA scaffolds. This indicates that proliferation 
may be driven by increased grain boundary area resulting 
from the smaller grain size, in addition to the optimum 
morphology in terms of pore size and pore interconnectivity 
(eg macro and microporosity) presented by our highly porous 
scaffolds. The basis for OB–HA adhesion and the effect of 
grain boundary volume on OB behavior are not completely 
understood, but may be linked in part to protein interactions 
at the surface (Webster et al 2000b). Webster et al (2000b) 
found that a decrease in grain size promoted an increase in 
vitronectin and collagen concentration and a decrease in 
albumin, laminin, and fibronectin concentration. They also 
linked the protein stereochemical structure to grain size and 
surface topography of bioceramic substrates (Webster et al 
2000b). Based on these findings, FBS proteins may adsorb 
more readily to nano HA scaffolds compared with micro HA 
scaffolds in this study, but this was not verified. The effect 
of FBS protein adsorption in vitro, contrasted with protein 
adsorption in an in vivo environment, should be investigated.
Other approaches to increasing OB attachment and 
proliferation on HA surfaces include peptide coating. For 
example, EEEEEEEPRGDT coating increased attachment at 
30 minutes compared with an HA control (Itoh et al 2002). 
GRGDSPC and cyclo-DfKRG increase osteoprogenitor 
cell attachment at 3 and 24 hours compared with untreated 
hydroxyapatite (Durrieu et al 2004). While these coatings 
increased OB attachment and proliferation, the smaller grain 
size found in our HA scaffolds is an intrinsic property, reducing 
the need for post-fabrication scaffold treatments such at the 
peptide coatings of Itoh et al (2002) and Durrieu et al (2004).
Although the use of nano HA in porous bone scaffolds 
does not initially improve OB attachment by 4 hours’ culture 
time, the apparent increase in proliferation of OBs at day 5 
shows the potential for more rapid osteoblast growth, and 
presumably more rapid calcification and bone formation in 
vitro. While further studies must be conducted to measure 
OB differentiation and calcium production over time in 
vitro, nano HA porous bone scaffolds, because of their 
increased grain boundary area and optimum pore size and 
interconnectivity, show promise as an effective bone scaffold 
for use in bone tissue engineering applications. 
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